Non-covalent ligand/DNA interactions: minor groove binding agents.
暂无分享,去创建一个
[1] P. Dervan,et al. Programmable oligomers targeting 5'-GGGG-3' in the minor groove of DNA and NF-kappaB binding inhibition. , 2007, Bioorganic & medicinal chemistry.
[2] Dale L Boger,et al. Sequence-selective DNA recognition: natural products and nature's lessons. , 2004, Chemistry & biology.
[3] J. Lah,et al. Energetic diversity of DNA minor-groove recognition by small molecules displayed through some model ligand-DNA systems. , 2004, Journal of molecular biology.
[4] K. Bielawski,et al. Synthesis, DNA binding, topoisomerase inhibition and cytotoxic properties of 2-chloroethylnitrosourea derivatives of hoechst 33258. , 2005, Biological & pharmaceutical bulletin.
[5] P. Dervan,et al. Cell-free and Cellular Activities of a DNA Sequence Selective Hairpin Polyamide-CBI Conjugate* , 2002, The Journal of Biological Chemistry.
[6] P. Baraldi,et al. DNA minor groove binders as potential antitumor and antimicrobial agents , 2004, Medicinal research reviews.
[7] Aklank Jain,et al. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy , 2006, Nucleic acids research.
[8] Binh Nguyen,et al. Design of a Hairpin Polyamide, ZT65B, for Targeting the Inverted CCAAT Box (ICB) Site in the Multidrug Resistant (MDR1) Gene , 2005, Chembiochem : a European journal of chemical biology.
[9] P. Dervan,et al. Toward artificial developmental regulators. , 2003, Journal of the American Chemical Society.
[10] L. EdwardsMichael,et al. Synthesis and DNA-binding properties of polyamine analogues. , 1991 .
[11] C. Wang,et al. Expanding the recognition of the minor groove of DNA by incorporation of beta-alanine in hairpin polyamides. , 2001, Bioorganic & medicinal chemistry.
[12] P. Dervan,et al. Recognition of the DNA minor groove by pyrrole-imidazole polyamides. , 2003, Current opinion in structural biology.
[13] P. Dervan,et al. Accessibility of nuclear chromatin by DNA binding polyamides. , 2003, Chemistry & biology.
[14] D. Paslier,et al. Human Chromosomal Fragile Site FRA16B Is an Amplified AT-Rich Minisatellite Repeat , 1997, Cell.
[15] M. N. Gupta,et al. The affinity concept in bioseparation: evolving paradigms and expanding range of applications. , 2006, Biomolecular engineering.
[16] B. Gatto,et al. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Shimamoto,et al. Quantitative analysis of Werner helicase activity using the single-molecule fluorescence detection system MF10S. , 2005, Biological & pharmaceutical bulletin.
[18] P. Dervan,et al. Nuclear localization of pyrrole–imidazole polyamide–fluorescein conjugates in cell culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] T. Hsu,et al. Induction of high frequencies of endoreduplication in mammalian cell cultures with 33258 Hoechst and rubidazone. , 1979, Cytogenetics and Cell Genetics.
[20] W. Wilson,et al. Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. , 2005, Current medicinal chemistry. Anti-cancer agents.
[21] J. Trauger,et al. Inhibition of Ets-1 DNA Binding and Ternary Complex Formation between Ets-1, NF-κB, and DNA by a Designed DNA-binding Ligand* , 1999, The Journal of Biological Chemistry.
[22] Suman Das,et al. Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. , 2003, Bioorganic & medicinal chemistry.
[23] G. Sutherland,et al. Heritable fragile sites on human chromosomes. XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17p12. , 1984, American journal of human genetics.
[24] W. Denny,et al. Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring. , 1981, Journal of medicinal chemistry.
[25] M. Sabatino,et al. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] D. Dasgupta,et al. Interaction of antitumor drug, mithramycin, with chromatin. , 2001, Biochemical and biophysical research communications.
[27] W. Denny,et al. DNA and the chromosome – varied targets for chemotherapy , 2004, Cell & chromosome.
[28] K. Luger,et al. Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. , 2001, Journal of molecular biology.
[29] M. McHugh,et al. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole. , 1989, Molecular pharmacology.
[30] K. Bielawski,et al. Synthesis, DNA-binding activity and cytotoxicity of carbamate derivatives of Hoechst 33258 in breast cancer MCF-7 cells. , 2002, Biological & pharmaceutical bulletin.
[31] D. Goodsell. Sequence recognition of DNA by lexitropsins. , 2001, Current medicinal chemistry.
[32] P. Wright,et al. Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor alpha with minor groove binding polyamides. , 2005, Biochemistry.
[33] P. Dervan,et al. Promoter Scanning for Transcription Inhibition with DNA-Binding Polyamides , 2002, Molecular and Cellular Biology.
[34] Peter B. Dervan,et al. Regulation of gene expression by small molecules , 1997, Nature.
[35] G. Fronza,et al. DNA damage and cytotoxicity induced by minor groove binding methyl sulfonate esters. , 2003, Biochemistry.
[36] Souvik Maiti,et al. Hoechst 33258 binds to G-quadruplex in the promoter region of human c-myc. , 2003, Biochemical and biophysical research communications.
[37] R. Blattes,et al. Target practice: aiming at satellite repeats with DNA minor groove binders. , 2005, Current medicinal chemistry. Anti-cancer agents.
[38] K. Vékey,et al. Combination of solid-phase affinity capture on magnetic beads and mass spectrometry to study non-covalent interactions: example of minor groove binding drugs. , 2005, Rapid communications in mass spectrometry : RCM.
[39] D. Dasgupta,et al. Association of anticancer drug mithramycin with H1-depleted chromatin: a comparison with native chromatin. , 2003, Journal of inorganic biochemistry.
[40] J. Griffith,et al. The [(G/C)3NN]n motif: a common DNA repeat that excludes nucleosomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] B. Gold,et al. Groove- and sequence-selective alkylation of DNA by sulfonate esters tethered to lexitropsins. , 1993, Biochemistry.
[42] J. Lown,,et al. Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes. , 1991, Biochimica et biophysica acta.
[43] P. Monti,et al. Nucleotide excision repair defect influences lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent in the absence of base excision repair. , 2004, Biochemistry.
[44] A. Inga,et al. Influences of Base Excision Repair Defects on the Lethality and Mutagenicity Induced by Me-lex, a Sequence-selective N3-Adenine Methylating Agent* , 2002, The Journal of Biological Chemistry.
[45] P. Dervan,et al. A Two-Hit Mechanism for Pre-Mitotic Arrest of Cancer Cell Proliferation by a Polyamide-Alkylator Conjugate , 2006, Cell cycle.
[46] W. Denny,et al. The mutagenic properties of DNA minor-groove binding ligands. , 1996, Mutation research.
[47] J. Petty,et al. Hydration changes in the association of Hoechst 33258 with DNA. , 2005, Biochemistry.
[48] W. Denny,et al. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258) , 1994, Journal of medicinal chemistry.
[49] N. Maizels,et al. Specific interactions of distamycin with G-quadruplex DNA. , 2003, Nucleic acids research.
[50] J. Trauger,et al. Minor groove DNA-protein contacts upstream of a tRNA gene detected with a synthetic DNA binding ligand. , 1999, Journal of molecular biology.
[51] A. Wolffe,et al. Nucleosome Assembly on Methylated CGG Triplet Repeats in the Fragile X Mental Retardation Gene 1 Promoter* , 1996, The Journal of Biological Chemistry.
[52] W. Denny,et al. Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA. , 1998, Anti-cancer drug design.
[53] Yuh-Hwa Wang,et al. Human Fragile Site FRA16B DNA Excludes Nucleosomes in the Presence of Distamycin* , 2002, The Journal of Biological Chemistry.
[54] P. Aich,et al. Role of Mg++ in the mithramycin-DNA interaction: evidence for two types of mithramycin-Mg++ complex. , 1990, Biochemical and biophysical research communications.
[55] Aneel K. Aggarwal,et al. Structure of a DNA-bound Ultrabithorax–Extradenticle homeodomain complex , 1999, Nature.
[56] N. Taulier,et al. Association of the minor groove binding drug Hoechst 33258 with d(CGCGAATTCGCG)2: volumetric, calorimetric, and spectroscopic characterizations. , 2005, Biochemistry.
[57] K. Luger,et al. Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands. , 2003, Journal of molecular biology.
[58] W. Denny,et al. Structures of two minor-groove-binding quinolinium quaternary salts complexed with d(CGCGAATTCGCG)(2) at 1.6 and 1.8 Angstrom resolution. , 2005, Acta crystallographica. Section D, Biological crystallography.
[59] Christopher L. Warren,et al. Defining the sequence-recognition profile of DNA-binding molecules. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Awasthi,et al. Triple helix stabilization by covalently linked DNA-bisbenzimidazole conjugate synthesized by maleimide-thiol coupling chemistry. , 2006, Bioorganic & medicinal chemistry.
[61] P. Cozzi. Recent outcome in the field of distamycin-derived minor groove binders. , 2000, Farmaco.
[62] A. Mikheikin,et al. Molecular Modelling of Ligand—DNA Minor Groove Binding: Role of Ligand—Water Interactions , 2001, Journal of Biomolecular Structure and Dynamics.
[63] M. Singh,et al. Synthesis and sequence-specific DNA binding of a topoisomerase inhibitory analog of Hoechst 33258 designed for altered base and sequence recognition. , 1992, Chemical research in toxicology.
[64] K. Doherty,et al. DNA helicases as targets for anti-cancer drugs. , 2005, Current medicinal chemistry. Anti-cancer agents.
[65] P. Dervan,et al. Binding affinities of synthetic peptides, pyridine-2-carboxamidonetropsin and 1-methylimidazole-2-carboxamidonetropsin, that form 2:1 complexes in the minor groove of double-helical DNA. , 1993, Biochemistry.
[66] Suman Das,et al. Binding of (MTR)2Zn2+ complex to chromatin: a comparison with (MTR)2Mg2+ complex. , 2005, Journal of inorganic biochemistry.
[67] Koichi Matsumoto,et al. Synthetic Pyrrole-Imidazole Polyamide Inhibits Expression of the Human Transforming Growth Factor-β1 Gene , 2005, Journal of Pharmacology and Experimental Therapeutics.
[68] P. Dervan,et al. Temperature-sensitive protein-DNA dimerizers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Snyder,et al. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. , 1991, Biochemistry.
[70] C. Benz,et al. Targeting the Ets Binding Site of the HER2/neuPromoter with Pyrrole-Imidazole Polyamides* , 2000, The Journal of Biological Chemistry.
[71] M. McHugh,et al. Effect of minor groove binding drugs on mammalian topoisomerase I activity. , 1989, Biochemical pharmacology.
[72] P. Ghanouni,et al. A DNA minor groove-binding ligand both potentiates and arrests transcription by RNA polymerase II. Elongation factor SII enables readthrough at arrest sites. , 1994, Journal of molecular biology.
[73] P. Dervan,et al. Small molecule transcription factor mimic. , 2004, Journal of the American Chemical Society.
[74] K. Fox,et al. Investigations into the sequence-selective binding of mithramycin and related ligands to DNA. , 1985, Nucleic acids research.
[75] P. Dervan,et al. Exploring the limits of benzimidazole DNA-binding oligomers for the hypoxia inducible factor (HIF) site. , 2006, Bioorganic & medicinal chemistry.
[76] W. Denny. DNA minor groove alkylating agents. , 2001, Current medicinal chemistry.
[77] Sherry M. Tsai,et al. Unanticipated differences between α- and γ-diaminobutyric acid-linked hairpin polyamide-alkylator conjugates , 2006, Nucleic acids research.
[78] W. Denny,et al. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles. , 1998, Journal of medicinal chemistry.
[79] A. Inga,et al. Relationship between DNA Methylation and Mutational Patterns Induced by a Sequence Selective Minor Groove Methylating Agent* , 1999, The Journal of Biological Chemistry.
[80] D. Wemmer,et al. Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[81] P. Dervan,et al. Arresting cancer proliferation by small-molecule gene regulation. , 2004, Chemistry & biology.
[82] G. Fronza,et al. The biological effects of N3‐methyladenine , 2004, Journal of cellular biochemistry.
[83] O. Cuvier,et al. Displacement of D1, HP1 and topoisomerase II from satellite heterochromatin by a specific polyamide , 2006, The EMBO journal.
[84] Y. Hiraku,et al. Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds. , 2004, Current medicinal chemistry. Anti-cancer agents.
[85] W. Denny,et al. Effects of anticancer drugs on transcription factor–DNA interactions , 2005, Expert opinion on therapeutic targets.
[86] T. C. Bruice,et al. DNA sequence recognition in the minor groove by hairpin pyrrole polyamide-Hoechst 33258 analogue conjugate. , 2004, Bioorganic & medicinal chemistry letters.
[87] Hans-Dieter Arndt,et al. Minimization of a protein-DNA dimerizer. , 2007, Journal of the American Chemical Society.
[88] R. Gellibolian,et al. Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. , 1996, Journal of molecular biology.
[89] W. Denny,et al. Structure of the d(CGCGAATTCGCG)2 Complex of the Minor Groove Binding Alkylating Agent Alkamin Studied by Mass Spectrometry , 2007, Molecular Pharmacology.
[90] W. Denny,et al. Minor groove binding of SN6999 to an alkylated DNA: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex. , 1993, Biochemistry.
[91] J. Lown,,et al. Bis-benzimidazole anticancer agents: targeting human tumour helicases. , 1999, Anti-cancer drug design.
[92] W. Denny,et al. Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues. , 1995, Mutation research.
[93] D. Baumann. [New drugs. 9]. , 1973, Pharmazeutische Praxis.
[94] C. Koller,et al. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. , 1991, The Journal of clinical investigation.
[95] J. Griffith,et al. Methylation of Expanded CCG Triplet Repeat DNA from Fragile X Syndrome Patients Enhances Nucleosome Exclusion* , 1996, The Journal of Biological Chemistry.
[96] D. Boger,et al. A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinity. , 2004, Accounts of chemical research.
[97] B. Vig,et al. Sequence of centromere separation: kinetochore formation in induced laggards and micronuclei. , 1986, Mutagenesis.
[98] M. Georgiadis,et al. A high-throughput, high-resolution strategy for the study of site-selective DNA binding agents: analysis of a "highly twisted" benzimidazole-diamidine. , 2006, Journal of the American Chemical Society.
[99] M. Jansen,et al. Advances in DNA-ligands with groove binding, intercalating and/or alkylating activity: chemistry, DNA-binding and biology. , 2005, Current medicinal chemistry.
[100] J. Kovach,et al. Phase I–II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma , 1991, Investigational New Drugs.
[101] P. Dervan,et al. Programmable DNA binding oligomers for control of transcription. , 2005, Current medicinal chemistry. Anti-cancer agents.
[102] F. Cavalli,et al. Phase I study of the novel distamycin derivative tallimustine (FCE 24517). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[103] Suman Das,et al. N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. , 2004, Biophysical chemistry.
[104] P. Dervan,et al. DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate. , 2003, Nucleic acids research.
[105] P. Dervan,et al. Sequence-specific fluorescence detection of DNA by polyamide-thiazole orange conjugates. , 2005, Journal of the American Chemical Society.
[106] T. C. Bruice,et al. Recognition of a 10 base pair sequence of DNA and stereochemical control of the binding affinity of chiral hairpin polyamide-Hoechst 33258 conjugates. , 2005, Bioorganic & medicinal chemistry letters.
[107] D. Boger,et al. A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity. , 2001, Journal of the American Chemical Society.
[108] P. Dervan,et al. DNA Damage Effects of a Polyamide-CBI Conjugate in SV40 Virions , 2005, Molecular Pharmacology.
[109] E. Long,et al. Fluorescent intercalator displacement analyses of DNA binding by the peptide-derived natural products netropsin, actinomycin, and bleomycin. , 2006, Bioorganic & medicinal chemistry.
[110] P. Aich,et al. Role of magnesium ion in mithramycin-DNA interaction: binding of mithramycin-Mg2+ complexes with DNA. , 1995, Biochemistry.
[111] R. Wells,et al. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.